Norbert Gattermann

15.7k citations
256 papers · 7.2k indexed · 1 hit paper · h-index 44
  • Hematology top 0.05%
    • Acute Myeloid Leukemia Research 152
    • Chronic Myeloid Leukemia Treatments 50
    • Hematopoietic Stem Cell Transplantation 21
    • Multiple Myeloma Research and Treatments 18
  • Genetics top 0.1%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 56
    • Chronic Lymphocytic Leukemia Research 54
    • Hemoglobinopathies and Related Disorders 45
  • Rheumatology top 0.5%
    • Histone Deacetylase Inhibitors Research 19

Norbert Gattermann

240 papers receiving 7.0k citations

Hit Papers

Nilotinib (formerly AMN107), a highly selective BCR-ABL t...5402007202620132019100200300400500

Peers

Norbert Gattermann
Comparison fields: 5 of 121
  • Hematology 5.6k
  • Genetics 3.7k
  • Rheumatology 1.1k
  • Emergency Medicine 421
  • Molecular Biology 2.1k
Replace Luca Malcovati with:
Luca Malcovati Italy
Rosangela Invernizzi Italy
Mary Frances McMullin United Kingdom
David Grimwade United Kingdom
David Bowen United Kingdom
Markus Schaich Germany
Paresh Vyas United Kingdom
Michael Heuser Germany
Felicetto Ferrara Italy
Jason Gotlib United States
Norbert Gattermann relative to Luca Malcovati Italy Luca Malcovati's profile →
Citations per field
00.5×2.8×
Luca Malcovati · 1×
Citations per year

Countries citing papers authored by Norbert Gattermann

Since Specialization
Citations

This map shows the geographic impact of Norbert Gattermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norbert Gattermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norbert Gattermann more than expected).

Fields of papers citing papers by Norbert Gattermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norbert Gattermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norbert Gattermann. The network helps show where Norbert Gattermann may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Norbert Gattermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Norbert Gattermann Line = papers co-authored together Norbert Gattermann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 202210
4 20221
5 202147
6 201914
7 20183
8 20176
9 20163
10 201211
11 201124
12 20081
13 20081
14 200724
15 200539
16 2005188
17 20046
18 200443
19 200449
20 1998111

About Norbert Gattermann

Norbert Gattermann is a scholar working on Hematology, Genetics and Rheumatology, having authored 256 papers that have together received 7.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (152 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (56 papers), Chronic Lymphocytic Leukemia Research (54 papers), Chronic Myeloid Leukemia Treatments (50 papers), Hemoglobinopathies and Related Disorders (45 papers), Hematopoietic Stem Cell Transplantation (21 papers), Histone Deacetylase Inhibitors Research (19 papers) and Multiple Myeloma Research and Treatments (18 papers). The work is most often cited by research in Hematology (5.6k citations), Genetics (3.7k citations) and Rheumatology (1.1k citations). Norbert Gattermann has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Ulrich Germing, Rainer Haas, Corinna Strupp, Ulrich Germing, Wolfgang Schneider, Carlo Aul, Manuel Aivado, Barbara Hildebrandt, Andreas Hochhaus and Francis J. Giles. Their work appears in journals such as Blood, Leukemia Research, Annals of Hematology, Leukemia and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026